Multiparticulate oral dosage form providing prolonged release of tapentadol
US-2025295596-A1 · Sep 25, 2025 · US
This page is not indexed by search engines while we improve data quality.
Schiller Marc patents
Schiller Marc is listed as an inventor on 17 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Schiller Marc |
| Total patents | 17 |
| First publication | Apr 23, 2015 |
| Latest publication | Sep 25, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Ethanolic resiniferatoxin concentrate
US-2025228775-A1 · Jul 17, 2025 · US
Aqueous pharmaceutical formulation of tapentadol for oral administration
US-11547678-B2 · Jan 10, 2023 · US
Stable formulation for parenteral administration of tapentadol
US-11013701-B2 · May 25, 2021 · US
Pharmaceutical dosage forms comprising 6′-fluoro-(N-methyl- or N,N-dimethyl-)-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine
US-10912763-B2 · Feb 9, 2021 · US
Parenteral administration of tapentadol
US-2020215003-A1 · Jul 9, 2020 · US
Multiparticulate oral dosage form providing prolonged release of tapentadol
US-2018369151-A1 · Dec 27, 2018 · US
Semisolid Aqueous Pharmaceutical Composition Containing Tapentadol
US-2018133174-A1 · May 17, 2018 · US
Stable Formulation for Parenteral Administration of Tapentadol
US-2018125800-A1 · May 10, 2018 · US
Pharmaceutical Dosage Forms Comprising 6'-Fluoro-(N-Methyl- or N,N-Dimethyl-)-4-Phenyl-4',9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano[3,4,b]Indol]-4-Amine
US-2016361294-A1 · Dec 15, 2016 · US
Recent patents
Latest publications not already listed above.
Semisolid Aqueous Pharmaceutical Composition Containing Tapentadol
US-2016346229-A1 · Dec 1, 2016 · US
Stable Formulation for Parenteral Administration of Tapentadol
US-2016279078-A1 · Sep 29, 2016 · US
Semisolid aqueous pharmaceutical composition containing tapentadol
US-9446008-B2 · Sep 20, 2016 · US
Aqueous Pharmaceutical Formulation of Tapentadol for Oral Administration
US-2016220516-A1 · Aug 4, 2016 · US
Parenteral Administration of Tapentadol
US-2016106688-A1 · Apr 21, 2016 · US
Pharmaceutical dosage forms comprising 6′-fluoro-(N-methyl- or N,N-dimethyl-)-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine
US-9289416-B2 · Mar 22, 2016 · US
Pharmaceutical Dosage Forms Comprising 6'-Fluoro-(N-Methyl- or N,N-Dimethyl-)-4-Phenyl-4',9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano[3,4,b]Indol]-4-Amine
US-2015111939-A1 · Apr 23, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Gruenenthal Gmbh | 17 |
| Reinhold Ulrich | 1 |
| Schiller Marc | 1 |
| Wulsten Eva | 1 |
| Inghelbrecht Sabine Karine Katrien | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K9/08 | 12 |
| A61K31/137 | 12 |
| A61P25/04 | 11 |
| A61K9/0053 | 8 |
| A61K47/10 | 8 |